Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - CYTOKINETICS INC | cytk-ex321_21.htm |
| EX-31.3 - EX-31.3 - CYTOKINETICS INC | cytk-ex313_475.htm |
| EX-31.2 - EX-31.2 - CYTOKINETICS INC | cytk-ex312_22.htm |
| EX-31.1 - EX-31.1 - CYTOKINETICS INC | cytk-ex311_23.htm |
| EX-10.48 - EX-10.48 - CYTOKINETICS INC | cytk-ex1048_584.htm |
| EX-10.47 - EX-10.47 - CYTOKINETICS INC | cytk-ex1047_585.htm |
| EX-10.45 - EX-10.45 - CYTOKINETICS INC | cytk-ex1045_682.htm |
| 10-K - 10-K - CYTOKINETICS INC | cytk-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-206795, 333-215147, and 333-221350) and Form S-8 (Nos. 333-115146, 333-125973, 333-133323, 333-136524, 333-140963, 333-149713, 333-152850, 333-161116, 333-168520, 333-176089, 333-183091, 333-190458, 333-206101, and 333-221348) of Cytokinetics, Incorporated of our report dated March 5, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, CA
March 5, 2018